Role of structural and extracellular virulence factors in gram-negative anaerobic bacteria

Clinical Infectious Diseases

Volumn 18, Issue , 1994, Pages S260-S264

  Botta, Giuseppe A ^a   Arzese, Alessandra ^a   Minisini, Rosalba ^a   Trani, Gabriella ^a  

^a Cattedra di Gastroenterologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A; OUTER MEMBRANE PROTEIN; PROTEINASE; SHORT CHAIN FATTY ACID; VIRULENCE FACTOR;

ABSCESS; ANAEROBIC INFECTION; BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; BACTERIUM PILUS; BACTEROIDES; BACTEROIDES FRAGILIS; CONFERENCE PAPER; ENZYME DEGRADATION; GRAM NEGATIVE ANAEROBIC BACTERIA; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL;

BACTERIA, ANAEROBIC; BACTERIAL CAPSULES; FIMBRIAE, BACTERIAL; GRAM-NEGATIVE BACTERIA; LIPOPOLYSACCHARIDES; SUPPORT, NON-U.S. GOV'T; VIRULENCE;

EID: 0028331531     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/18.Supplement_4.S260     Document Type: Article

References (38)

1. Mayrand D. Holt SC. Biology of asaccharolytic black-pigmented Bac-leroides species. Microbiol Rev 1988;52:134-52.
2. Styrt B. Gorbach SI. Recent developments in the understanding of thepathogenesis and treatment of anaerobic infections. New Engl J Med 1989;321:240-6, 298-302.
3. Hofstad T. Virulence factors in anaerobic bacteria. Eur J Clin Microbiol Infect Dis 1992; 11:1044-8.
4. Patrick S. The virulence of Bacteroides fmgtl'ts. Rev Med Microbiol 1993;4:40-9. '
5. Kasper DL. Bacterial capsule—old dogmas and new tricks. J Infect Dis1986;153:407-15.
6. Onderdonk AB, Cisneros RL, Finberg R, Crabb JH, Kasper DL. Animal model system for studying virulence of and host response to Bacteroidesfragilis. Rev Infect Dis 1990;l2(suppl 2):S169—77.
7. Lindberg AA. Weintraub A. Encapsulation and protection againstphagocytosis by Bacteroides fragilis. Scand J Infect Dis Suppl 1985;46:27-32.
8. Namavar F, Theunissen EB, Verweji-van Vught AM. Epidemiology ofthe Bacteroides fragilis group in the colonic flora of patients with colonic cancer. J Med Microbiol 1989;29:171-6.
9. Babb JL, Cummins CS. Encapsulation of Bacteroides species. InfcctImmun 1978;19:1088-91.
10. Gollapudi SVS, Gupta A, Thadepalli H, Perez A. Use of lymphokinesin treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.Infect Immun 1988;56:2369-72.
11. Lindberg AA. Weintraub A, Zähringer U. Rietschel ETH. Structure-ac-tivity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 1990:12(suppl 2):S133-41.
12. Corio R, Radin L, Botta GA. Carattcrizzazione chimica del lipopolisac-caride del B. endodontalis mediante HPLC. Biochimica Clinica 1990;14:181-5.
13. Joiner KA, McAdam KPWJ, Kasper DL. Lipopolysaccharides fromBacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice. Infect Immun 1982;36:1139-45.
14. Nair BC, Mayberry WR, Dziak R. Chen PB, Levine MJ, Hausmann E.Biological effects of a purified lipoplysaccharide from Bacteroides gingimUs.J Periodont Res 1983;18:40-9.
15. Koga T, Nishihara T, Fujiwara T, et al. Biochemical and immunobiolo-gical properties of lipopolysaccharide (LPS) from Bacteroides gingiva-lis and comparison with LPS from Escherichia coli.Infect Immun 1985;47:638-47.
16. Johne B, Olsen I, Bryn K. Fatty acids and sugars in lipopolysaccharidesfrom Bacteroides intermedias. Bacteroides gingivalis and Bacteroides loeschii.Oral Microbiol Immunol 1988;3:22-7.
17. Williams GD, Holt SC. Characteristics of the outer membrane of selected oral Bacteroides species. Can J Microbiol 1985;31:238-50.
18. Costa A. Botta GA, Schito GC. Ortisi G, Privitera G, Menozzi MG.High homology of membrane proteins electrophoretic pattern in Bacteroides fragilis as confirmed by various solubilizing methods. Microbiologica 1986:9:1-11.
19. Bullen JJ. The significance of iron in infection. Rev Infect Dis1981:3:1127-38.
20. Neilands JB. Microbial envelope proteins related to iron. Annu RevMicrobiol 1984;36:285-309.
21. Otto BR, Verweij-van Vught AMJJ, van Doom J, Maclaren DM. Outermembrane proteins of Bacteroides fragilis and Bacteroides vulgatus in relation to iron uptake and virulence. Microb Pathog 1988;4: 279-87.
22. Otto BR, Verweij WR, Sparrius M, Verweij-van Vught AMJJ, NordCE, MacLaren DM. Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilis.Infect Immun 1991;59:2999-3003.
23. Elleman TC. Pilins of Bacteroides nodosus. Molecular basis for serotypicvariation and relationships to other bacterial pilins. Microbiol Rev 1988;52:233-47.
24. Pruzzo C. Dainelli B. Ricchetti M. Piliated Bacteroides fragilis strainsadhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains. Infect Immun 1984;43:189-94.
25. van Doom J. Mooi FR. Verweij-van Vught AMJJ, MacLaren DM.Characterization of fimbriae from Bacteroides fragilis.Microb Pathog 1987;3:87-95.
26. Pruzzo C, Guzman CA, Dainelli B. Incidence of hemagglutination activity among pathogenic and non-pathogenic Bacteroides fragilis strains and role of capsule and pili in HA and adherence. FEMS Microbiol Lett 1989,-59:113-8.
27. Okuda K. Yamamoto A, Naito Y, Takazoe I, Slots J, Genco RJ. Purifi-cation and properties of hemagglutinin from culture supernatant of Bacleroides gingivalis.Infect Immun 1986;54:659-65.
28. Ingham HR, Sisson PR, Tharagonnet D, Selkon JB, Codd AA. Inhibition ofphagocytosis in vitro by obligate anaerobes. Lancet 1977;2:1252-4.
29. Tonetti M, Eftimiadi C, Damiani G, Bufla P, Buffa D, Botta GA. Shortchain fatty acids present in periodontal pockets may play a role in human periodontal diseases. J Periodont Res 1987;22:190-1.
30. Botta GA, Radin L, Costa A. Gas liquid chromatography of gingivalfluid as an aid in periodontal diagnosis. J Periodont Res 1985;20:450-7.
31. Botta GA, Eftimiadi C, Costa A, Tonetti M, van Steenbergen TJM, deGraaff J. Influence of volatile fatty acids on human granulocytes chemotaxis. FEMS Microbiol Let 1985;27:69-72.
32. Rotstein OD, Pruett TL, Fiegel VD. Succinic acid, a metabolic byproduct of Bacleroides species, inhibits polymorphonuclear leukocyte functions. Infect Immun 1985;48:402-8.
33. Rotstein OD, Vittorini T, Kao J, McBurney MI, Nasmith PE, Grinstein S. A soluble Bacleroides by-product impairs phagocytic killing of Escherichia coli by neutrophils. Infect Immun 1989;57:745-53.
34. Pirlo P, Arzese A, Cavallero A, Botta GA. Inhibitory effect of shortchain fatty acids produced by anaerobic bacteria on the phagocytosis of Staphylococcus aureus by human granulocytes. In: Hardie JM, Bordello SP, eds. Anaerobes today. New York: John Wiley & Sons Inc., 1988:223-34.
35. Eftimiadi C, Buzzi E, Tonetti M, et al. Short-chain fatty acids producedby anaerobic bacteria alter the physiological responses of human neutrophils to chemotactic peptide. J Infect 1987;14:43-53.
36. Tonetti M, Cavallero A, Botta GA, Niederman R, Eftimiadi C. Intracellular pH regulates the production of different oxygen metabolites in neutrophils: effects of organic acids produced by anaerobic bacteria. J Leukoc Biol 1991;49:180-8.
37. Kilian M, Thomsen B, Petersen TE, Bleeg HS. Occurrence and natureof bacterial IgA proteases. Ann N Y Acad Sci 1983;409:612-24.
38. Senior BW, Loomes LM, Kerr MA. Microbial IgA proteases and virulence. Rev Med Microbiol 1991;2:200-7.